Similarly, clinical stage, histological subtype, residual tumor, tumor invasion, and ZDHHC1 expression were significantly associated with a shorter DSS and PFI in the patients (Tables 2 and 3). The gene discussed is ZDHHC1; the disease is neoplasm.